PACAP and VIP Inhibit the Invasiveness of Glioblastoma Cells Exposed to Hypoxia through the Regulation of HIFs and EGFR Expression

Aleppo, 1992, Metabotropic glutamate receptors and neuronal toxicity., Adv. Exp. Med. Biol., 318, 137, 10.1007/978-1-4615-3426-6_12

Barrie, 1997, Pituitary adenylyl cyclase-activating peptide stimulates extracellular signal-regulated kinase 1 or 2 (ERK1/2) activity in a Ras-independent, mitogen-activated protein Kinase/ERK kinase 1 or 2-dependent manner in PC12 cells., J. Biol. Chem., 272, 19666, 10.1074/jbc.272.32.19666

Blehm, 2006, Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy., Clin. Cancer Res, 12, 4671, 10.1158/1078-0432.CCR-06-0407

Brenneman, 2007, Neuroprotection: a comparative view of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide., Peptides, 28, 1720, 10.1016/j.peptides.2007.04.002

Canonico, 1996, Activation of pituitary adenylate cyclase-activating polypeptide receptors prevents apoptotic cell death in cultured cerebellar granule cells., Ann. N. Y. Acad. Sci., 26, 470

Casibang, 2001, Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells., Lung Cancer, 31, 203, 10.1016/S0169-5002(00)00168-9

Castorina, 2010a, Effects of PACAP and VIP on hyperglycemia-induced proliferation in murine microvascular endothelial cells., Peptides, 31, 2276, 10.1016/j.peptides.2010.08.013

Castorina, 2012, Involvement of PACAP/ADNP signaling in the resistance to cell death in malignant peripheral nerve sheath tumor (MPNST) cells., J. Mol. Neurosci., 48, 674, 10.1007/s12031-012-9755-z

Castorina, 2014, PACAP and VIP increase the expression of myelin-related proteins in rat schwannoma cells: involvement of PAC1/VPAC2 receptor-mediated activation of PI3K/Akt signaling pathways., Exp. Cell Res., 10, 108, 10.1016/j.yexcr.2013.11.003

Castorina, 2008, PACAP and VIP prevent apoptosis in schwannoma cells., Brain Res., 1241, 29, 10.1016/j.brainres.2008.09.035

Castorina, 2010b, Early effects of aluminum chloride on beta-secretase mRNA expression in a neuronal model of beta-amyloid toxicity., Cell Biol. Toxicol., 26, 367, 10.1007/s10565-009-9149-3

Cavallaro, 1995, Differentiation induces pituitary adenylate cyclase-activating polypeptide receptor expression in PC-12 cells., Mol. Pharmacol., 48, 56

Chetram, 2012, PTEN regulation of ERK1/2 signaling in cancer., J. Recept. Signal. Transduct. Res., 32, 190, 10.3109/10799893.2012.695798

Cochaud, 2015, Neuropeptides of the VIP family inhibit glioblastoma cell invasion., J. Neurooncol., 122, 63, 10.1007/s11060-014-1697-6

Couvineau, 2003, Identification of cytoplasmic domains of hVPAC1 receptor required for activation of adenylyl cyclase. Crucial role of two charged amino acids strictly conserved in class II G protein-coupled receptors., J. Biol. Chem., 278, 24759, 10.1074/jbc.M301916200

D’Agata, 1998, Functional and molecular expression of PACAP/VIP receptors in the rat retina., Brain Res. Mol. Brain Res., 54, 161, 10.1016/S0169-328X(97)00335-5

D’Agata, 1996, Tissue-specific and developmental expression of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in rat brain., Euro. J. Neurosci., 8, 310, 10.1111/j.1460-9568.1996.tb01215.x

D’Agata, 2000, Regional and cellular expression of the parkin gene in the rat cerebral cortex., Euro. J. Neurosci., 12, 3583, 10.1046/j.1460-9568.2000.00244.x

D’Amico, 2013, Antiproliferative effects of PACAP and VIP in serum-starved glioma cells., J. Mol. Neurosci., 51, 503, 10.1007/s12031-013-0076-7

Dejda, 2008, Inhibitory effect of PACAP on caspase activity in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases., J. Mol. Neurosci., 36, 26, 10.1007/s12031-008-9087-1

Delgado, 1999, Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit interleukin-12 transcription by regulating nuclear factor kappaB and Ets activation., J. Biol. Chem., 274, 31930, 10.1074/jbc.274.45.31930

Dickson, 2006, A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC/PAC receptor pharmacology., Neuropharmacology, 51, 1086, 10.1016/j.neuropharm.2006.07.017

Dickson, 2009, VPAC and PAC receptors: from ligands to function., Pharmacol. Ther., 121, 294, 10.1016/j.pharmthera.2008.11.006

Dunn, 2012, Emerging insights into the molecular and cellular basis of glioblastoma., Genes Dev., 26, 756, 10.1101/gad.187922.112

Epstein, 2001, C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation., Cell, 107, 43, 10.1016/S0092-8674(01)00507-4

Franovic, 2007, Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer., Proc. Natl. Acad. Sci. U.S.A., 7, 13092, 10.1073/pnas.0702387104

Franovic, 2009, Human cancers converge at the HIF-2alpha oncogenic axis., Proc. Natl. Acad. Sci. U.S.A., 106, 21306, 10.1073/pnas.0906432106

Fujiwara, 2007, Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas., Int. J. Oncol., 30, 793

Giunta, 2010, PACAP and VIP affect NF1 expression in rat malignant peripheral nerves heath tumor (MPNST) cells., Neuropeptides, 44, 45, 10.1016/j.npep.2009.10.003

Giunta, 2012, Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats., Peptides, 37, 32, 10.1016/j.peptides.2012.06.004

Halatsch, 2006, Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours., Cancer Treat. Rev., 32, 74, 10.1016/j.ctrv.2006.01.003

Harmar, 2012, Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclaseactivating polypeptide: IUPHAR review 1., Br. J. Pharmacol., 2166, 4, 10.1111/j.1476-5381.2012.01871.x

Helczynska, 2008, Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer., Cancer Res., 68, 9212, 10.1158/0008-5472.CAN-08-1135

Hirsilä, 2005, Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway., FASEB J., 19, 1308, 10.1096/fj.04-3399fje

Holmquist-Mengelbier, 2006, Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype., Cancer Cell, 10, 413, 10.1016/j.ccr.2006.08.026

Isobe, 2003, Expression of mRNA for PACAP and its receptors in intra- and extra-adrenal human pheochromocytomas and their relationship to catecholamine synthesis., Regul. Pept., 110, 213, 10.1016/S0167-0115(02)00209-4

Jaworski, 2000, Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors, and in response to acute intracranial injury., Cell Tissue Res., 300, 219, 10.1007/s004410000184

Juarranz, 2001, Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptors., Cell. Signal., 13, 887, 10.1016/S0898-6568(01)00199-1

Kaur, 2005, Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis., Neuro Oncol., 7, 134, 10.1215/S1152851704001115

Kim, 2009, The critical role of ERK in death resistance and invasiveness of hypoxia-selected glioblastoma cells., BMC Cancer, 9, 10.1186/1471-2407-9-27

Koh, 2011, The hypoxia-associated factor switches cells from HIF-1a to HIF-2a-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion., Cancer Res., 71, 4015, 10.1158/0008-5472.CAN-10-4142

Koh, 2012, Passing the baton: the HIF switch., Trends Biochem. Sci., 37, 364, 10.1016/j.tibs.2012.06.004

Koul, 2008, PTEN signaling pathways in glioblastoma., Cancer Biol. Ther., 7, 1321, 10.4161/cbt.7.9.6954

Laburthe, 2002, VPAC receptors for VIP and PACAP., Recept Chann., 8, 137, 10.3109/10606820213680

Lelièvre, 1998, Differential effects of peptide histidine isoleucine (PHI) and related peptides on stimulation and suppression of neuroblastoma cell proliferation. A novel VIP-independent action of PHI via MAP kinase., J. Biol. Chem., 273, 19685, 10.1074/jbc.273.31.19685

Li, 1997, PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer., Science, 275, 1943, 10.1126/science.275.5308.1943

Lim, 2004, Ras-dependent induction of HIF-1alpha785 via the Raf/MEK/ERK pathway: a novel mechanism of Ras-mediated tumor promotion., Oncogene, 23, 9427, 10.1038/sj.onc.1208003

Liu, 2013, Transcriptional signaling pathways inversely regulated in Alzheimer’s disease and glioblastoma multiform., Sci. Rep., 10, 10.1038/srep03467

Magro, 2011, Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target., Thyroid, 21, 267, 10.1089/thy.2010.0173

Maugeri, 2015, Expression profile of parkin isoforms in human gliomas., Int. J. Oncol., 47, 1282, 10.3892/ijo.2015.3105

Maugeri, 2016, Parkin modulates expression of HIF-1α and HIF-3α during hypoxia in gliobastoma-derived cell lines in vitro., Cell Tissue Res., 10.1007/s00441-015-2340-3

Maynard, 2004, Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer., Am. J. Nephrol., 24, 1, 10.1159/000075346

Moody, 2001, VIP receptor antagonists potentiate the action of chemotherapeutic drugs on breast cancer cells., Breast Cancer Res. Treat., 68, 55, 10.1023/A:1017994722130

Mottet, 2002, ERK and calcium in activation of HIF-1., Ann. N. Y. Acad. Sci., 973, 448, 10.1111/j.1749-6632.2002.tb04681.x

Nakada, 2007, Molecular targets of glioma invasion., Cell Mol Life Sci., 64, 458, 10.1007/s00018-007-6342-5

Oka, 1998, Pituitary adenylate-cyclase–activating polypeptide (PACAP) binding sites and PACAP/vasoactive intestinal polypeptide receptor expression in human pituitary adenomas., Am. J. Pathol., 153, 1787, 10.1016/S0002-9440(10)65693-3

Park, 2011, Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1alpha mediated by the PTEN/PI3K/Akt pathway., Oncogene, 10, 4578, 10.1038/onc.2011.174

Qing, 2009, Hypoxia inducible factor- 2alpha: a critical mediator of aggressive tumor phenotypes., Curr. Opin. Genet. Dev., 19, 60, 10.1016/j.gde.2008.12.001

Reglodi, 2011, Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo., Curr. Pharm. Des., 17, 962, 10.2174/138161211795589355

Reubi, 2000, Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin., Cancer Res., 60, 3105

Robberecht, 1993, Receptors for pituitary adenylate cyclase activating peptides in human pituitary adenomas., J. Clin. Endocrinol. Metab., 77, 1235, 10.1210/jc.77.5.1235

Robberecht, 1994, Expression of pituitary adenylate cyclase activating polypeptide (PACAP) receptors in human glial cell tumors., Peptides, 15, 661, 10.1016/0196-9781(94)90092-2

Schulz, 2004, Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies., Clin. Cancer Res., 10, 8235, 10.1158/1078-0432.CCR-04-0939

Seaborn, 2011, Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis., Curr. Pharm. Des., 17, 204, 10.2174/138161211795049679

Semenza, 1999a, Perspectives on oxygen sensing., Cell, 98, 281, 10.1016/S0092-8674(00)81957-1

Semenza, 1999b, Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1., Annu. Rev. Cell Dev. Biol., 15, 551, 10.1146/annurev.cellbio.15.1.551

Sherwood, 2000, The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily., Endocr. Rev., 21, 619, 10.1210/er.21.6.619

Song, 2012, The functions and regulation of the PTEN tumour suppressor., Nat. Rev. Mol. Cell Biol., 13, 283, 10.1038/nrm3330

Sonoda, 2001a, Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma., Cancer Res., 61, 6674

Sonoda, 2001b, Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma., Cancer Res., 61, 4956

Tang, 2014, Vasoactive intestinal peptide receptor-based imaging and treatment of tumors., Int. J. Oncol., 44, 1023, 10.3892/ijo.2014.2276

Tian, 1997, Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells., Genes Dev., 11, 72, 10.1101/gad.11.1.72

Vaudry, 2009, Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery., Pharmacol. Rev., 61, 283, 10.1124/pr.109.001370

Vaudry, 2000, Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions., Pharmacol. Rev., 52, 269

Vertongen, 1996, VIP and pituitary adenylate cyclase activating polypeptide (PACAP) have an antiproliferative effect on the T98G human glioblastoma cell line through interaction with VIP 2 receptor., Neuropeptides, 30, 491, 10.1016/S0143-4179(96)90015-3

Waschek, 2013, VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair., Br. J. Pharmacol., 169, 512, 10.1111/bph.12181

Wen, 2008, Malignant gliomas in adults., N. Engl. J. Med., 359, 492, 10.1056/NEJMra0708126

Whitmarsh, 1996, Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways., J. Mol. Med., 74, 589, 10.1007/s001090050063

Zagzag, 2006, Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion., Lab. Invest., 86, 1221, 10.1038/labinvest.3700482

Zhang, 2011, Astragaloside IV stimulates angiogenesis and increases HIF-1{alpha} accumulation via PI3K/Akt pathway., J. Pharmacol. Exp. Ther., 338, 485, 10.1124/jpet.111.180992